$0.614
+0.002 (+0.28%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de RNTX por análisis de gráficos similares
Alphio's RNTX stock price prediction model matches the current Rein Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.60 (-1.86%). The 1-week path is $0.61 (-0.70%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Rein Therapeutics Inc?
Rein Therapeutics, Inc. (RNTX) appears to be a good buy right now due to its recent positive developments, including receiving FDA Fast Track designation for its drug LTI-03, which addresses a significant unmet need in idiopathic pulmonary fibrosis. The stock is currently priced at $0.64, significantly below its 52-week high of $2.18, indicating potential for recovery. Additionally, the stock has shown a 5-day change of +8.95%, suggesting a recent upward momentum. However, the main risk is its negative earnings per share (EPS) of -0.10 expected in the upcoming earnings report, which could impact investor sentiment.
RNTX cerró en $0.61 el Friday, tras subir +0.28%
Rein Therapeutics Inc (RNTX) last closed at $0.6099, losing -0.34%. These facts feed the 1-day and 1-week RNTX price prediction above.
Factores de la previsión
Los factores de la previsión de Rein Therapeutics Inc (RNTX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de RNTX, ordenadas por similitud.
Análisis de estacionalidad de RNTX
Historically the probability of a positive November return for RNTX is 22.73%. April offers the highest probability of a positive month at 64.06%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de RNTX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.15 | $1.27 | $1.41 | +107.86% |
| Dec 2026 | $1.16 | $1.49 | $1.71 | +144.06% |
En 2026, se proyecta que Rein Therapeutics Inc (RNTX) oscile entre $1.15 y $1.71.
Previsión mensual de Rein Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Rein Therapeutics Inc promedie $1.27, con un mínimo de $1.15 y un máximo de $1.41.
En Dec de 2026, se proyecta que Rein Therapeutics Inc promedie $1.49, con un mínimo de $1.16 y un máximo de $1.71.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.